Results 111 to 120 of about 54,621 (145)

PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome. [PDF]

J Clin Med
Beck DB, Heiblig M, Savic S, Ferrada MA, Mekinian A, Chowdhury O, Hammond D, Weeks LD, Gurnari C, Kirino Y, Georgin-Lavialle S, Buckley SA, Garcha R, Harder BG, Koster MJ.   +14 more
europepmc   +1 more source

CHA₂DS₂-VASc scores to predict left atrial/left atrial appendage abnormalities in patients with sepsis-induced atrial fibrillation: A preliminary investigation. [PDF]

J Intensive Med
Labbé V, Ederhy S, Legouis D, Joffre J, Razazi K, Sy O, Chemouni F, Mekontso Dessap A, Fartoukh M, Cohen A.   +9 more
europepmc   +1 more source

Prevalence of thromboembolic events in critically-ill COVID-19 patients infected with Omicron: results from the French prospective, multicenter SEVARVIR cohort study. [PDF]

Crit Care
Bay P, Audureau E, Fourati S, de Prost N, SEVARVIR investigators.   +4 more
europepmc   +1 more source

Renal Mass Biopsy Prior to Surgical Excision: Practice, Diagnostic Performance, and Impact on Management in the UroCCR Registry (Ancillary Study No. 118). [PDF]

Eur Urol Open Sci
Proye P, Gondran-Tellier B, Michel F, Bensalah K, Bigot P, Audenet F, Champy C, Merlin P, Bruyere F, Roupret M, Marcq G, Surlemont L, Parier B, Waeckel T, Michel C, Branger N, Tricart T, Sarrazin C, Patard JJ, Vallée M, Beauval JB, Fontenil A, Mallet R, Guillotreau J, Panthier F, Belas O, Vergie S, Clerc QL, Doumerc N, Taha F, Rouget B, Gimel P, Bernhard JC, Boissier R.   +33 more
europepmc   +1 more source

Refined genotype-phenotype correlations in neurofibromatosis type 1 patients with <i>NF1</i> point variants. [PDF]

J Med Genet
Pacot L, Blok M, Vidaud D, Fertitta L, Laurendeau I, Coustier A, Maillard T, Barbance C, Hadjadj D, Ye M, Lallemand D, Ferkal S, Funalot B, Lunati-Rozie A, Hebrard B, Bhouri R, Spruijt L, Bessis D, Geneviève D, Vernimmen V, Broen MPG, Sigaudy S, Odent S, Damaj L, Quélin C, Pasquier L, Layet V, Gilbert-Dussardier B, Nicolas G, Guerrot AM, Leheup B, Bursztejn AC, Petit F, Boute-Bénéjean O, Capri Y, Guimier A, Lyonnet S, Baujat G, Bourrat E, Isidor B, Nizon M, Barbarot S, Toutain A, Blesson S, Van-Gils J, Morice-Picard F, Audebert-Bellanger S, Mazereeuw-Hautier J, Ziegler A, Alembik Y, Piard J, Brischoux-Boucher E, Guerrini-Rousseau L, Morera J, Paquis-Flucklinger V, Delobel B, Alessandri JL, Parfait B, NF-France network, Wolkenstein P, Pasmant E.   +60 more
europepmc   +1 more source

Associations between frailty, biomarkers of cerebral pathology, cognitive and neuropsychiatric symptoms: a memory clinic study. [PDF]

J Frailty Aging
Gilles V, Flaus A, Teillac A, Verny M, Blanc F, Paccalin M, Desmidt T, Louchart de la Chapelle S, Dumay C, Sauvée M, Lehmann S, Hirtz C, Cotton F, Bathsavanis A, Gervais F, Novais T, Desestret V, Boublay N, Krolak-Salmon P, Dautricourt S, Garnier-Crussard A.   +20 more
europepmc   +1 more source

Provider Perspectives on Medication for AUD in Mental Health and Substance Use Disorder Clinics. [PDF]

J Dual Diagn
Kacmarek CN, Kreyenbuhl J, Hagedorn HJ, H Brown C, Richardson EJ, Spaderna M, Marks MR, Bennett ME, Roche DJO.   +8 more
europepmc   +1 more source

Impacts of immune checkpoint inhibitors use on the HIV reservoir are linked to provirus sequences but not integration sites. [PDF]

Sci Rep
Guiraud V, Fauchois A, Soulie C, Leducq V, Veyri M, Assoumou L, Boutolleau D, Costagliola D, Lambotte O, Spano JP, Pourcher V, Marcelin AG, Calvez V.   +12 more
europepmc   +1 more source

Pentosan Polysulfate and Heparin Exhibit Comparable Interactions with Platelet Factor 4, Suggesting a Potential Risk of Thrombocytopenia. [PDF]

ACS Omega
Nizzolo S, Zanzoni S, Holthoff HP, Girasole M, Gruber R, Lenhart D, Yates E, Guerrini M, Bertini S.   +8 more
europepmc   +1 more source

Higher levels of host-cell DNA methylation markers ZNF582 and ASCL1 on anal smears are predictive for progression to anal cancer in patients with previous high-grade lesions. [PDF]

EBioMedicine
Ferré VM, Dupont A, Draullette M, Valette E, Collin G, Bucau M, Siproudhis L, Staumont G, Roy C, Hesselink AT, Bouchard D, Radenne S, Spindler L, Naji A, Bergeron C, Couvelard A, Descamps D, Steenbergen RDM, Charpentier C, Abramowitz L, AIN3 National Cohort, GREP.   +21 more
europepmc   +1 more source